Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06452771
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-05
Brief Title:
A First In Human FIH Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals